BioSpace

5 Therapies Moving the Multiple Myeloma Space Forward

A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...
Targeted Oncology

SUCCESSOR-2 Study Shows PFS Benefit With Mezigdomide in Relapsed Myeloma

Mezigdomide (a CELMoD) combined with carfilzomib/dexamethasone met the phase 3 primary endpoint, delivering statistically ...
Healio

Regimen confers ‘clinically meaningful’ PFS benefit in relapsed multiple myeloma

Please provide your email address to receive an email when new articles are posted on . CHICAGO — The addition of belantamab mafodotin to pomalidomide and dexamethasone improved outcomes compared with ...
Business Wire

Rallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced preliminary Phase 1 multiple ascending dose (MAD) data for RLYB116, an innovative, long-acting, low volume ...
Business Wire

Rallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced preliminary data from the completed multiple dose cohort of the Phase 1 safety and pharmacokinetics (PK) study ...
ascopubs.org

Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia

Asparaginase treatment is standard in all pediatric acute lymphoblastic leukemia (ALL) regimens, whereas in adults, it is either excluded or administered for a shorter duration. Several adult ALL ...
Targeted Oncology

Interpreting Outcomes With Dose-Reduced Selinexor in Relapsed Myeloma

There is a lot that we learned from BOSTON, and there’s a lot that we’re still learning. There was a time where bortezomib was intravenous twice weekly. Now…it’s once weekly subcutaneous, and ...